Published May 12, 2021 | Version 1

Data: Firefly Luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies

  • 1. Cellular Therapies Laboratory, NHS Blood and Transplant, Liverpool, UK
  • 2. Department of Molecular Physiology and Cell Signalling, University of Liverpool, Liverpool, UK
  • 3. Department of Pharmacology & Therapeutics, University of Liverpool, Liverpool, UK

Description

This data set includes all the raw data collected for the following article: "Firefly Luciferase offers superior performance to AkaLuc for tracking the fate of administered cell therapies".

Notes

This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions, grant agreement No 813839, Innovative Training Network RenalToolBox

Files

Animal Experiments.zip

Files (1.6 GB)

Name Size
md5:8f983d1b303aaa4cce8475b8469c02c7
401.2 MB Preview Download
md5:9c79ddf986ef7b5396b90ed0bdf3d3dc
1.2 GB Preview Download